| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000018026 |
| Receipt No. | R000020885 |
| Official scientific title of the study | Evaluation of tear volume change by abdominal breathing in dry eye disease patients |
| Date of disclosure of the study information | 2015/06/22 |
| Last modified on | 2016/06/23 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Evaluation of tear volume change by abdominal breathing in dry eye disease patients | |
| Title of the study (Brief title) | Evaluation of tear volume change by abdominal breathing in dry eye disease patients | |
| Region |
|
|
| Condition | ||
| Condition | dry eye | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the change of tear volume by parasympathetic effect with abdominal breathing for dry eye disease patients |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Strip tear Meniscometry value
heart rate variability body temperature around eye tear film break-up time tear meniscus height DEQS QIDS-J |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | behavior intervention | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | People who provided written consent form on their voluntary basis
People who were diagnosed as dry eye disease |
|||
| Key exclusion criteria | People who didn't provid written consent form
People who couldn't do abdominal breathing by some reason Pregnant women |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Motoko Kawashima |
| Organization | Keio University School of Medicine |
| Division name | Ophthalmology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| TEL | 03-5363-3866 |
| motoko-k@a3.keio.jp | |
| Public contact | |
| Name of contact person | Kokoro Sano |
| Organization | Keio University School of Medicine |
| Division name | Ophthalmology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| TEL | 03-5363-3866 |
| Homepage URL | |
| kokoro.sano@keio.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine,
Department of Ophthalmology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Keio University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020885 |